05/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

05/2024

May 11, 2024, 12:21 | Blog
Ariana Pelosci: Cancer Network team and I visited Memorial Sloan Kettering Cancer Center to film the next installment of Breaking Barriers
Ariana Pelosci, Editor at MJH Life Sciences, shared on LinkedIn: "Yesterday the Cancer Network team…
May 11, 2024, 12:13 | Insight
Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: "Comprehensive mutational scanning of EGFR…
May 11, 2024, 12:11 | Blog
Phuong Ly-Gallagher: Validation that the work you are doing makes a difference
Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared a post by…
May 11, 2024, 12:05 | Blog
Nina Niu Sanford: Nice editorial urging caution in patients with near CR after total neoadjuvant therapy in rectal cancer
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared a…
May 11, 2024, 11:58 | Drugs
David Fajgenbaum: How is the price of a drug
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:…
May 11, 2024, 11:49 | Blog
Ben Smith: Is it reasonable to assume that PROMs data are missing at random?
Ben Smith, Senior Implementation Scientist at The Daffodil Centre, shared a post on X: "Is it…
May 11, 2024, 11:44 | Blog
Inocras Inc. announces collaboration with AstraZeneca and the Cancerinformation.com.hk Charity Foundation
Inocras Inc. shared on LinkedIn: "We're thrilled to announce our collaboration with AstraZeneca and the Cancerinformation.com.hk…
May 11, 2024, 11:39 | Blog
Julia Maués: HER2-positive, HER2-low, HER2-shy
Julia Maués, Co-Founder of Grasp Cancer, shared a post by Paolo Tarantino on X and…
May 11, 2024, 11:32 | Blog
Vivek Subbiah: Future of early-phase drug development and precision medicine is bright at Gustave Roussy Cancer Center!
Vivek Subbiah shared a post by Adrien Mouren, on X and added: "Future of early-phase…
May 11, 2024, 11:23 | Insight
Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow
Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…
All: 2435 Posts: 1751 - 1760
Special Coverage